Risk of Total Events With Icosapent Ethyl
Open accessThe claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In REDUCE-IT, benefits of icosapent ethyl on total ischemic events were consistent across baseline and achieved triglyceride levels.
“Analysis of total ischemic events (first and subsequent events) found a significant 30% reduction, with consistent benefits across baseline and achieved triglyceride levels.5–9”
From REDUCE-IT USA: Results From the 3146 Patients Randomized in the United States (2020) · cites this paper as [9]
Analysis of total ischemic events in REDUCE-IT found a significant 30% reduction.
“Analysis of total ischemic events (first and subsequent events) found a significant 30% reduction, with consistent benefits across baseline and achieved triglyceride levels.5–9”
From REDUCE-IT USA: Results From the 3146 Patients Randomized in the United States (2020) · cites this paper as [9]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients
Mack, M. J., Leon, M. B., Thourani, V. H., Makkar, R., Kodali, S., Russo, M. J., Kapadia, S. R., Malaisrie, S. C., Cohen, D. J., Pîbarot, P., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1814052 · Cited by 4,895 · see citing works
Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients
Popma, J. J., Deeb, G. M., Yakubov, S. J., Mumtaz, M. A., Gada, H., O’Hair, D. P., BAJWA, T. K., Heiser, J. C., Merhi, W. M., Kleiman, N. S., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1816885 · Cited by 3,684 · see citing works
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
Bhatt, D. L., Steg, P. G., Miller, M., Brinton, E. A., Jacobson, T. A., Ketchum, S. B., Doyle, R. T., Juliano, R. A., Jiao, L., Granowitz, C., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1812792 · Cited by 3,317 · see citing works
Transcatheter Mitral-Valve Repair in Patients with Heart Failure
Stone, G. W., Lindenfeld, J., Abraham, W. T., Kar, S., Lim, D. S., Mishell, J. M., Whisenant, B., Grayburn, P. A., Rinaldi, M., Kapadia, S. R., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1806640 · Cited by 3,017 · see citing works
Yokoyama, M., Origasa, H., Matsuzaki, M., Matsuzawa, Y., Saito, Y., Ishikawa, Y., Oikawa, S., Sasaki, J., Hishida, H., Itakura, H., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60527-3 · Cited by 2,516 · see citing works
Percutaneous Repair or Medical Treatment for Secondary Mitral Regurgitation
Obadia, J., Messika–Zeitoun, D., Leurent, G., Iung, B., Bonnet, G., Piriou, N., Lefèvre, T., Piot, C. A., Rouleau, F., Carrié, D., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1805374 · Cited by 1,812 · see citing works
Aung, T., Halsey, J., Kromhout, D., Gerstein, H. C., Marchioli, R., Tavazzi, L., Geleijnse, J. M., Rauch, B., Ness, A., Galan, P., et al. (2018) · JAMA Cardiology · doi:10.1001/jamacardio.2017.5205 · Cited by 632 · see citing works
Effects of Icosapent Ethyl on Total Ischemic Events
Bhatt, D. L., Steg, P. G., Miller, M., Brinton, E. A., Jacobson, T. A., Ketchum, S. B., Doyle, R. T., Juliano, R. A., Jiao, L., Granowitz, C., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.02.032 · Cited by 259 · see citing works
Nicholls, S. J., Lincoff, A. M., Bash, D., Ballantyne, C. M., Barter, P. J., Davidson, M. H., Kastelein, J. J. P., Koenig, W., McGuire, D. K., Mozaffarian, D., et al. (2018) · Clinical Cardiology · doi:10.1002/clc.23055 · Cited by 167 · see citing works
REDUCE-IT USA: Results From the 3146 Patients Randomized in the United States
Bhatt, D. L., Miller, M., Brinton, E. A., Jacobson, T. A., Steg, P. G., Ketchum, S. B., Doyle, R. T., Juliano, R. A., Jiao, L., Granowitz, C., et al. (2020) · Circulation · doi:10.1161/circulationaha.119.044440 · Cited by 136 · see citing works
Nishio, R., Shinke, T., Otake, H., Nakagawa, M., Nagoshi, R., Inoue, T., Kozuki, A., Hariki, H., Osue, T., Taniguchi, Y., et al. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.02.025 · Cited by 133 · see citing works
FISHing for the Miracle of Eicosapentaenoic Acid
Kastelein, J. J. P., & Stroes, E. S. G. (2019) · New England Journal of Medicine · doi:10.1056/nejme1814004 · Cited by 74 · see citing works
Yamano, T., Kubo, T., Shiono, Y., Shimamura, K., Orii, M., Tanimoto, T., Matsuo, Y., Ino, Y., Kitabata, H., Yamaguchi, T., et al. (2015) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.25593 · Cited by 40 · see citing works
WHAT MADE MY HEART STOP? A RARE CAUSE OF SUDDEN CARDIAC ARREST
Hussain, M. A., Nabi, F., Awar, M., & Valderrábano, M. (2019) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(19)33397-2 · Cited by 13 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
REDUCE-IT USA: Results From the 3146 Patients Randomized in the United States
Bhatt, D. L., Miller, M., Brinton, E. A., Jacobson, T. A., Steg, P. G., Ketchum, S. B., Doyle, R. T., Juliano, R. A., Jiao, L., Granowitz, C., et al. (2020) · Circulation · doi:10.1161/circulationaha.119.044440 · Cited by 136 · see citing works
Anti-Inflammatory Effects of Lipid-Lowering Drugs and Supplements—A Narrative Review
Živković, S., Maric, G. D., Cvetinovic, N., Lepojevic-Stefanovic, D., & Božić, B. (2023) · Nutrients · doi:10.3390/nu15061517 · Cited by 74 · see citing works
Nelson, A. J., Ardissino, M., Haynes, K., Shambhu, S., Eapen, Z. J., McGuire, D. K., Carnicelli, A., Lópes, R. D., Green, J. B., O'Brien, E. C., et al. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.120.016835 · Cited by 55 · see citing works
Self-citationPeterson, B. E., Bhatt, D. L., Steg, P. G., Miller, M., Brinton, E. A., Jacobson, T. A., Ketchum, S. B., Juliano, R. A., Jiao, L., Doyle, R. T., et al. (2022) · Journal of the American Heart Association · doi:10.1161/jaha.121.022937 · Cited by 46 · see citing works
Statistical methods for composite endpoints
Hara, H., Klaveren, D. V., Kogame, N., Chichareon, P., Modolo, R., Tomaniak, M., Ono, M., Kawashima, H., Takahashi, K., Capodanno, D., et al. (2021) · EuroIntervention · doi:10.4244/eij-d-19-00953 · Cited by 36 · see citing works
Cardiovascular risk reduction with icosapent ethyl
Patel, P. N., Patel, S. M., & Bhatt, D. L. (2019) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000678 · Cited by 33 · see citing works
Weintraub, W. S., Bhatt, D. L., Zhang, Z., Dolman, S. F., Boden, W. E., Bress, A. P., King, J. B., Bellows, B. K., Tajeu, G. S., Derington, C. G., et al. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.48172 · Cited by 28 · see citing works
Weintraub, W. S., Bhatt, D. L., Zhang, Z., Dolman, S. F., Boden, W. E., Bress, A. P., Bellows, B. K., Derington, C. G., Philip, S., Steg, P. G., et al. (2023) · Journal of the American Heart Association · doi:10.1161/jaha.123.032413 · Cited by 7 · see citing works
- Authors
- Granger, C. B., Nelson, A. J., & Pagidipati, N. J.
- Affiliations
- Duke Medical Center (US)
- Corresponding author
- Granger, Christopher B.
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2019-06
- Volume
- 73
- Issue
- 22
- Pages
- 2803-2805
- ISSN
- 0735-1097 (ISSN-L)
- OpenAlex
- W2948369279
- Cited by
- 8
- References
- 14
- Citations by year
- 2023: 2 · 2022: 2 · 2021: 2 · 2019: 2
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Journal of the American College of Cardiology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Pfizer
- AstraZeneca
- Regeneron Pharmaceuticals
- Amarin Corporation
- Medicines Company
- Novo Nordisk
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Health Sciences › Medicine › Surgery › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Acute Myocardial Infarction Research
- Keywords
- icosapent ethyl, eicosapentaenoic acid, cardiovascular events, cardiovascular mortality, myocardial infarction, stroke, coronary revascularization, unstable angina, confidence intervals
- MeSH terms
- Humans, Eicosapentaenoic Acid, Hypertriglyceridemia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
